Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT07139379
Recruiting Not applicable

Effects of Virtual Reality Multisensory Cooperative Task-Oriented Mirror Therapy

NCT07139379 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2025-06-24
Last updated
2026-04-15

Condition(s) studied

StrokeRehabilitationVirtual RealityMirror Movement TherapyTask Performance

Investigational drug(s) / intervention(s)

task-oriented trainingVirtual Reality Mirror TherapyVirtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy

task-oriented training: Motor training targeted to goals that are relevant to the functional needs of the patient

Virtual Reality Mirror Therapy: Virtual Reality Mirror Therapy using goggle

Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy: Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy using goggle

Study summary

In the proposed study, the investigators assumed that Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Therapy (VRMCTOMT) will provide a better treatment effects than traditional virtual reality mirror therapy (VRMT) for the patients with unilateral stroke. The aim of the study is to examine the difference in the treatment effects among the combination of task-oriented training with either VRMCTOMT, or VRMT on the upper extremity function and brain activity of the stroke patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Clinical diagnosis of stroke with unilateral side involved; * A score of Mini-mental state examination greater than 24 for proving higher mental function * Time of onset \> 6 months before treatment begins; and * Premorbid right-handedness. Exclusion Criteria: * Severe vision impairment; * Major cognitive-perceptual deficit; * Other brain disease.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Cheng-Kung University Hospital Tainan Taiwan Recruiting

More National Cheng-Kung University Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07139379 on ClinicalTrials.gov ↗ ← All trials in Taiwan